# Edison trajectory: 09-organizer-persona-mock-review

- **Task ID:** `6e00f3ca-b077-4ea6-83d4-4a30b63b7af5`
- **Job:** `job-futurehouse-paperqa3-high` (`LITERATURE_HIGH`)
- **Status:** `success`
- **Edison platform link:** https://platform.edisonscientific.com/tasks/6e00f3ca-b077-4ea6-83d4-4a30b63b7af5
- **Motivation:** One more Edison pass on the *latest* (Edison-`06`-edited) abstract in [`crutch-tip-abstract.md`](../crutch-tip-abstract.md) — a **mock program-committee / peer review** written from the personas of the four TMS 2027 *Biomedical Materials and Devices: From Laboratory to Market* symposium organizers (Amit Bandyopadhyay, Anil Sachdev, Trey Rodgers, Susmita Bose), against the symposium's full published scope from the [TMS 2027 CFA flyer](https://www.tms.org/tms2027/downloads/flyers/TMS2027-CFA-Flyer-017.pdf).
- **Verdict (one line):** **submit-with-substantial-revisions** — overall *borderline / weak accept* at this symposium; strongest fix is to foreground the closed-loop Bayesian-optimization / AI-driven-design angle, temper the prior-art and regulatory claims, and add one translational metric.

---

Question: 
You are convening a mock program-committee / peer-review panel for a conference
abstract submitted to the TMS 2027 symposium "Biomedical Materials and Devices:
From Laboratory to Market." Provide critical mock-reviewer feedback and specific,
actionable revision suggestions. Ground every factual assessment in the literature
and cite sources.

=== THE SYMPOSIUM (verbatim scope, TMS 2027 CFA flyer) ===
Innovation in biomaterials and medical devices has saved millions of lives over the
years. However, there exists a big disconnect between laboratory research in academia
and the current need to bring some of those devices to the marketplace. An open
conversation amongst the stakeholders is vital to minimize this knowledge gap. The
symposium will focus on knowledge transfer amongst researchers from academia, industry,
regulatory bodies, and end users, such as physicians and members of the funding agencies.
Topics include intelligent manufacturing methods, applications of artificial intelligence
and machine learning (AI/ML) in manufacturing biomedical devices, and innovative
characterization tools to test properties in vitro that can better correlate in vivo
performances. Some of the current challenges in biomedical devices include mitigating
infection risks in implants, minimizing the anisotropic properties of additively
manufactured materials, improving fatigue resistance of additively manufactured metallic
implants, designing new alloys for biodegradable metallic implants, and enhancing the
biocompatibility of current alloys. Some of the knowledge gaps in innovative biomaterials
include the use of natural medicinal compounds (NMCs) in medical devices, bioprinting of
personalized implants, high-strength biodegradable ceramic implants, designing smart
implants with an inherent ability to generate surface charge for faster healing, and so
on. While the academic researchers can present innovative ideas, members of the industry
and regulatory bodies can share the current knowledge gaps in product maturation. Along
with regular presentations, this symposium will also organize panel discussions on
multidisciplinary topics relevant to the next generation of biomedical devices. Through
such cross-cutting information exchange, this symposium aims to focus on more effective
biomedical materials research involving all stakeholders.

=== THE ORGANIZER PERSONAS (review as each; these are the symposium organizers) ===
Adopt each organizer's known research/professional perspective and give feedback in that
voice. For each, note what would excite them and what would trigger a critical question:
1. Amit Bandyopadhyay (Washington State University) — additive manufacturing of biomaterials,
   metal/ceramic AM, functionally graded and multi-material AM, laser-based AM of implants,
   natural medicinal compounds in devices, translational orthopedic devices.
2. Anil Sachdev (University of North Texas; long automotive/GM materials background) —
   structural materials, manufacturing, mechanical behavior, lightweighting, industrial
   materials engineering and scale-up perspective.
3. Trey Rodgers (Zimmer Biomet) — industry / orthopedic medical-device commercialization,
   regulatory maturation, design controls, manufacturing for market, product realization.
4. Susmita Bose (Washington State University) — 3D-printed bioceramics/scaffolds, drug
   delivery, surface modification, biocompatibility, bone tissue engineering, NMCs.

=== THE ABSTRACT UNDER REVIEW (TMS 2027, <=150 words, plain text) ===
Title: Bayesian-Optimized Multi-Material 3D-Printed Tensegrity Crutch Tips for Impact
Attenuation
Authors: Marcus Madsen*, Audrey Christiansen*, Jinkwan Han*, Jeffrey R. Hill (presenting),
Sterling G. Baird — Department of Mechanical Engineering, Brigham Young University.

Long-term crutch users load each crutch to roughly 0.5 body weights during
partial-weight-bearing gait and experience substantial upper-extremity overuse injury,
including crutch palsy, shoulder impingement, and carpal tunnel syndrome, yet commercial
crutch tips still predominantly rely on rubber ferrules or bulky spring dampers. We present
a shock-absorbing crutch-tip insert built from multi-material fused-filament-fabrication
tensegrity-inspired lattices that pair rigid PETG struts with elastomeric TPU tension
elements, exploiting buckling-induced load-limiting plateaus and TPU viscoelastic
hysteresis. Because the standard 19 to 25 mm crutch-shaft interface constrains insert
stroke, we co-optimize unit-cell topology, strut diameter, relative density, and prestress
using closed-loop multi-objective Bayesian optimization, maximizing specific energy
absorption while minimizing peak transmitted force across quasi-static compression and
drop-weight impact tests. A prior-art survey found no crutch tip applying tensegrity
architectures, and an anticipated FDA Class I (21 CFR 890.3790) pathway under ISO 11334-1
applies. This design study advances miniaturized, patient-tunable absorbers for assistive
devices.

=== WHAT WE NEED FROM YOU ===
1. MOCK REVIEW SCORECARD: Give an overall accept/weak-accept/borderline/reject leaning for
   this abstract at THIS symposium, plus per-criterion scores (novelty, technical merit,
   fit-to-symposium-scope, clarity, translational/lab-to-market strength, evidence
   sufficiency). Be candid: this is a polymer FFF assistive-device abstract submitted to a
   symposium whose named challenges skew toward metallic/ceramic implants, biodegradable
   alloys, biocompatibility, and in vitro/in vivo correlation. Assess the fit-gap honestly
   and say whether it is acceptable or a stretch.
2. PER-ORGANIZER FEEDBACK: For each of the four organizers, give (a) the single question
   they are most likely to ask at the podium/panel, and (b) one concrete change that would
   most improve the abstract in their eyes. Tie to their expertise (e.g., Bandyopadhyay on
   multi-material AM interfaces & functionally graded design; Sachdev on manufacturing
   scale-up & mechanical behavior; Rodgers on design controls / 510(k) / product
   maturation; Bose on surface/biocompatibility & translational framing).
3. LAB-TO-MARKET ALIGNMENT: The symposium's thesis is closing the academia->market gap.
   Rate how well the abstract speaks to that thesis and give 2-3 concrete, citation-backed
   sentences or metrics we could add within the 150-word limit (e.g., device-abandonment
   rate, cost-of-illness, distributed/point-of-care AM economics, design-control/regulatory
   maturation steps, reimbursement/DME pathway).
4. FACT-CHECK & OVERSTATEMENT PASS: Re-verify any remaining questionable claims (0.5 BW
   framing; "substantial" overuse-injury burden; "predominantly rely on rubber ferrules or
   bulky spring dampers" vs. existing shock-absorbing ferrule prior art; the tensegrity
   novelty claim; FDA Class I / 21 CFR 890.3790 / ISO 11334-1 for a novel insertable
   absorber). Flag anything a stakeholder reviewer would challenge and give defensible
   wording.
5. SCOPE-FIT REPOSITIONING: Because the symposium emphasizes AI/ML in biomedical
   manufacturing and intelligent manufacturing methods, advise how to foreground the
   Bayesian-optimization / closed-loop-AI-driven-design angle so the abstract lands
   squarely in-scope. Suggest a retitle or reframed opening sentence if warranted.
6. CONCRETE REWRITES: Provide 3-5 specific, drop-in edit suggestions (each <=25 words) that
   stay within the 150-word TMS limit, plus an optional one-sentence "market/translation"
   clause we could add if we trim elsewhere.
7. VERDICT IN ONE LINE: submit-as-is / submit-with-minor-edits / substantially-revise /
   consider-a-different-symposium — with a one-sentence justification.

Cite literature for all clinical, biomechanical, materials, and regulatory claims.


# Mock Program-Committee Review: "Bayesian-Optimized Multi-Material 3D-Printed Tensegrity Crutch Tips for Impact Attenuation"

**Submitted to:** TMS 2027 Symposium — *Biomedical Materials and Devices: From Laboratory to Market*

---

## 1. MOCK REVIEW SCORECARD

The following scorecard reflects a candid assessment of the abstract against the specific priorities and scope of this symposium.

| Criterion | Score (1-5 scale) | Comment |
|---|---:|---|
| Novelty | 4.0 | Applying tensegrity-inspired, multi-material lattices to a crutch-tip insert appears novel at the crutch-tip level, even though tensegrity impact absorbers are established more broadly; Bayesian optimization is also timely for AM lattice design (pajunen2019designandimpact pages 5-7, gongora2024acceleratingthedesign pages 6-7, zhang2021bayesianoptimisationfor pages 8-11). |
| Technical Merit | 3.5 | The mechanics premise is credible: buckling-induced load-limiting plateaus are well supported in 3D-printed tensegrity structures, and multi-objective Bayesian optimization is an appropriate search strategy; however, the abstract gives no quantitative outcomes and does not address PETG/TPU interface integrity, a known issue in multi-material FFF (pajunen2019designandimpact pages 5-7, pajunen2019designandimpact pages 7-8, bandyopadhyay2018additivemanufacturingof pages 3-6). |
| Fit-to-Symposium-Scope | 2.5 | This is a biomedical device and it does align with the symposium’s AI/ML-in-manufacturing theme, but it is still a stretch relative to the stated emphasis on implants, metallic/ceramic biomaterials, biodegradables, and in vitro/in vivo correlation (gongora2024acceleratingthedesign pages 2-4, bandyopadhyay20213dprintingof pages 8-8, bandyopadhyay20203dprintingfor pages 1-2). |
| Clarity | 4.0 | The abstract is compact, readable, and technically articulate for a 150-word limit; the core design variables and claimed contributions are clear. The main clarity issue is slight overstatement around prior art and regulatory certainty (US11712394B1 pages 1-4, US11712394B1 pages 12-14). |
| Translational/Lab-to-Market Strength | 2.5 | The FDA Class I / ISO framing helps, but the pathway is simplified for a novel insert that changes device mechanics; no design controls, verification/validation plan, cost target, reimbursement/DME angle, or manufacturing scale-up considerations are included (bandyopadhyay20213dprintingof pages 8-8, mottaghi2025opensource3dprintable pages 1-6). |
| Evidence Sufficiency | 2.0 | The submission reads as a design-study concept: there are no reported peak-force reductions, SEA values, cycle life, or comparison to commercial ferrules/spring-loaded designs, so reviewers must infer performance rather than evaluate it directly (pajunen2019designandimpact pages 5-7, gongora2024acceleratingthedesign pages 10-11, US11712394B1 pages 1-4). |
| Overall Recommendation | Borderline / Weak Accept | Acceptable only if substantially revised to foreground the closed-loop AI/ML design contribution, temper the prior-art/regulatory claims, and add one concrete translational metric or result. As written, it is interesting but scope-adjacent and under-evidenced for a lab-to-market symposium (sugawara2018abandonmentofassistive pages 6-6, gongora2024acceleratingthedesign pages 10-11, bandyopadhyay20213dprintingof pages 8-8). |


*Table: This table summarizes a candid mock scorecard for the abstract against the symposium’s priorities. It highlights where the work is strongest—novelty and clarity—and where revisions are most needed, especially scope fit, evidence, and translation.*

**Overall Leaning: Borderline / Weak Accept.** The abstract presents a genuinely novel application of tensegrity-inspired lattices to crutch-tip absorbers combined with closed-loop Bayesian optimization—a timely AI/ML-in-manufacturing contribution. However, the fit to this symposium is a stretch. The call for abstracts explicitly names metallic/ceramic implants, biodegradable alloys, biocompatibility, infection mitigation, fatigue of AM metallic implants, NMCs, bioprinting, and in vitro/in vivo correlation (bandyopadhyay20213dprintingof pages 8-8, bandyopadhyay20203dprintingfor pages 1-2). A polymer FFF assistive-device abstract is scope-adjacent at best. The abstract would be a stronger fit at a symposium on assistive technology, mechanical metamaterials, or AM design optimization. That said, the symposium does explicitly list AI/ML in manufacturing biomedical devices and innovative characterization tools, which provides a defensible if narrow foothold.

---

## 2. PER-ORGANIZER FEEDBACK

Feedback below is written in the voice of each organizer, reflecting their known research perspectives and likely concerns.

| Organizer | Most Likely Podium Question | One Concrete Change to Improve the Abstract |
|---|---|---|
| Amit Bandyopadhyay (WSU) | Your PETG/TPU multi-material interface is the weakest link in this lattice—what is the interfacial shear strength under cyclic impact loading, and how does thermal mismatch during co-extrusion affect delamination risk? Multi-material AM literature shows thermal expansion/contraction mismatch can compromise part integrity (bandyopadhyay2018additivemanufacturingof pages 3-6, bandyopadhyay20213dprintingof pages 8-8). | Add one sentence quantifying PETG/TPU interfacial bond strength or delamination test results to demonstrate multi-material interface reliability (bandyopadhyay2018additivemanufacturingof pages 3-6). |
| Anil Sachdev (UNT / ex-GM) | What is the fatigue life of this insert under 10^6 simulated gait cycles, and how does the PETG strut buckling response degrade over time? Repeated crutch loading is central to aided gait mechanics, so durability—not just initial impact attenuation—matters for manufacturable productization (chamorromoriana2016acompactforearm pages 8-10, pajunen2019designandimpact pages 5-7). | Include a fatigue/durability metric such as cycles to failure, peak-force drift, or stiffness retention after N cycles to address reliability and scale-up concerns (pajunen2019designandimpact pages 5-7, pajunen2019designandimpact pages 7-8). |
| Trey Rodgers (Zimmer Biomet) | You cite FDA Class I exempt under 21 CFR 890.3790, but this novel insert fundamentally changes the crutch's mechanical response—have you engaged FDA to confirm the classification, and where is your design history file and risk analysis? Existing crutch-accessory regulation is a starting point, not proof of pathway certainty for a novel shock-absorbing insert (US11712394B1 pages 12-14, mottaghi2025opensource3dprintable pages 1-6). | Replace the confident regulatory assertion with hedged language such as “an anticipated Class I accessory pathway under 21 CFR 890.3790, pending regulatory confirmation,” and mention design controls / risk analysis. |
| Susmita Bose (WSU) | This is a skin-contact device used during wound recovery—have you characterized PETG and TPU biocompatibility for skin-contact use, and is there any concern about particulate generation from buckling strut wear? Symposium priorities emphasize biocompatibility and device maturation, not just mechanics (bandyopadhyay20213dprintingof pages 8-8, bandyopadhyay20213dprintingof pages 2-3). | Add one clause addressing skin-contact biocompatibility and wear/debris screening to better align with the symposium’s biocompatibility emphasis. |


*Table: This table translates each organizer’s likely research or commercialization lens into one high-value podium question and one specific abstract revision. It is useful for tailoring the submission to the symposium’s additive-manufacturing, translation, and biocompatibility priorities.*

**Bandyopadhyay** would be intrigued by the multi-material AM angle—his group's extensive work on multi-material structures demonstrates that thermal expansion/contraction mismatches between co-deposited materials are a fundamental integrity risk (bandyopadhyay2018additivemanufacturingof pages 3-6). PETG and TPU have very different glass transition temperatures and thermal expansion coefficients, and the abstract does not address interfacial bond characterization. **Sachdev**, with his automotive-materials and manufacturing-scale-up lens, would immediately ask about cyclic durability: a crutch user may load each insert >2,000 times daily, and PETG strut buckling under repeated cycling could accumulate plastic strain even if single-impact residual strain is low (pajunen2019designandimpact pages 5-7, pajunen2019designandimpact pages 7-8). **Rodgers** would challenge the regulatory framing directly: while 21 CFR 890.3790 does cover crutch accessories as Class I exempt, a novel insert that fundamentally alters the device's mechanical response may require FDA engagement to confirm classification; additionally, no design controls, risk analysis (ISO 14971), or verification/validation plan is mentioned (US11712394B1 pages 12-14, bandyopadhyay20213dprintingof pages 8-8). **Bose** would note the complete absence of biocompatibility or biological considerations—this is a skin-contact device used during wound recovery, and ISO 10993 cytotoxicity and sensitization screening would be expected for any biomedical device symposium presentation (bandyopadhyay20213dprintingof pages 2-3).

---

## 3. LAB-TO-MARKET ALIGNMENT

**Rating: Weak (2.5/5).** The symposium's central thesis is closing the academia-to-market gap through cross-cutting stakeholder dialogue. The abstract mentions the FDA/ISO pathway but otherwise reads as a pure design study with no market-facing content.

**Three citation-backed sentences or metrics that could be added within the 150-word limit:**

1. *Abandonment metric:* "Crutch abandonment rates reach 31%, partly attributable to poor ergonomics and comfort" — this grounds the clinical need in a concrete market failure (sugawara2018abandonmentofassistive pages 6-6, sugawara2018abandonmentofassistive pages 4-5).

2. *Distributed manufacturing economics:* Desktop FFF enables distributed, point-of-care manufacturing of assistive devices at very low material cost; open-source 3D-printed crutch components have been demonstrated at <CAD $36 in material, suggesting the tensegrity insert could be produced for a few dollars per unit, dramatically below injection-molded spring-loaded damper assemblies (brown2020commonproblemswith pages 1-7).

3. *Design-control maturation:* A one-clause mention of ISO 14971 risk analysis and design verification/validation per FDA design controls (21 CFR 820.30) would demonstrate awareness of product maturation steps, which is precisely what the symposium's industry and regulatory panelists want to hear (bandyopadhyay20213dprintingof pages 8-8).

---

## 4. FACT-CHECK & OVERSTATEMENT PASS

**Claim: "~0.5 body weights during partial-weight-bearing gait."** This is defensible. Chamorro-Moriana et al. (2016) explicitly tested crutch loading at 50% BW as a standard partial-weight-bearing prescription, measuring approximately 25–27 kg per crutch at that level (chamorromoriana2016acompactforearm pages 8-10). Hügle et al. (2017) confirm that approximately one-third of load is absorbed by the forearm during crutch walking and that crutch walking requires twice the energy of normal gait (hugle2017prospectiveclinicalevaluation pages 1-3). However, 0.5 BW represents the upper end of prescribed partial weight bearing; many clinical protocols prescribe 10–25% BW. **Suggested rewording:** "…up to ~0.5 BW per crutch during partial-weight-bearing gait."

**Claim: "substantial upper-extremity overuse injury."** This is supported but could be more precise. Hügle et al. (2017) document ulnar neuropraxia, forearm hematoma, and skin injury from crutch use (hugle2017prospectiveclinicalevaluation pages 1-3). Oh et al. (2017) show crutch users have elevated rotator cuff retear rates. However, the abstract conflates specific conditions (crutch palsy, shoulder impingement, carpal tunnel) without distinguishing prevalence. **Suggestion:** Use "documented upper-extremity complications including neuropraxia and shoulder overuse" instead of listing all three syndromes.

**Claim: "predominantly rely on rubber ferrules or bulky spring dampers."** This is an oversimplification. Patent prior art reveals a rich history of shock-absorbing ferrule designs: US Patent 4,252,138 (Fowler) describes rubber ferrules; US Patent 8,820,339 (Goodwin) discloses walking aids with central compression springs and variable axial resilience; US Patent 11,712,394 (Spatorico, 2023) describes a compression-spring-plus-viscoelastic ferrule specifically targeting crutch palsy; and WO2010069070A1 (Doherty, 2010) catalogs hydraulic, pneumatic, and elastomeric damper solutions dating to an 1841 U.S. patent (US11712394B1 pages 1-4, US11712394B1 pages 14-16, US11712394B1 pages 12-14, WO2010069070A1 pages 23-25). The abstract should acknowledge these exist and position tensegrity lattices as offering architected tunability that spring/rubber systems lack, rather than implying a technological vacuum.

**Claim: "no crutch tip applying tensegrity architectures."** This appears defensible based on our search. No tensegrity-based crutch-tip patent or publication was identified. However, tensegrity joints for prosthetic/orthotic devices do exist (US20110093091A1, Rifkin 2011), and tensegrity-inspired 3D-printed impact absorbers have been extensively demonstrated for other applications (pajunen2019designandimpact pages 5-7, pajunen2019designandimpact pages 1-2, pajunen2019designandimpact pages 8-9). The claim should be narrowed explicitly: "no tensegrity-based crutch-tip absorber was identified in the prior-art literature" to avoid implying broader structural novelty.

**Claim: "FDA Class I (21 CFR 890.3790) pathway under ISO 11334-1 applies."** The regulation 21 CFR 890.3790 does cover "walking aid, cane, crutch, and accessories" as Class I, generally exempt from 510(k) premarket notification. ISO 11334-1:2007 is the correct standard for forearm crutches, and has been used in recent 3D-printed crutch validation studies (mottaghi2025opensource3dprintable pages 1-6). However, a novel insert that changes the device's mechanical response through compliant lattice buckling may warrant FDA pre-submission engagement to confirm the accessory classification. The confident "applies" should be softened to "anticipated" (bandyopadhyay20213dprintingof pages 8-8, US11712394B1 pages 12-14).

---

## 5. SCOPE-FIT REPOSITIONING

The symposium explicitly calls for "applications of artificial intelligence and machine learning (AI/ML) in manufacturing biomedical devices" and "intelligent manufacturing methods." This is the abstract's strongest in-scope hook, and it should be foregrounded aggressively. Bayesian optimization for lattice design is a rapidly growing area: Gongora et al. (2024) demonstrated that BO achieves an 82% reduction in design iterations relative to grid search for AM lattice structures (gongora2024acceleratingthedesign pages 10-11, gongora2024acceleratingthedesign pages 2-4); Vangelatos et al. (2021) showed that Bayesian evolutionary Monte Carlo sampling achieved a 12,464-fold improvement in strain energy density for architected materials (vangelatos2021strengththroughdefects pages 1-2); and Zhang et al. (2021) reviewed BO for sequential experimental design in additive manufacturing specifically (zhang2021bayesianoptimisationfor pages 8-11).

**Recommended repositioning strategy:**
- Lead the title and opening sentence with "closed-loop Bayesian optimization" and "AI-driven design" rather than burying it mid-abstract.
- Frame the tensegrity crutch tip as a *case study* for an AI/ML-accelerated biomedical device design methodology applicable to broader AM biomaterial design problems.
- Explicitly connect to the symposium's distributed/point-of-care manufacturing theme by noting that BO-optimized parametric lattices can be patient-customized at the point of care.

**Suggested retitle:** "Closed-Loop Bayesian Optimization of Multi-Material 3D-Printed Tensegrity Lattices for Shock-Absorbing Assistive-Device Inserts"

**Suggested reframed opening sentence:** "Closed-loop multi-objective Bayesian optimization accelerates the design of patient-tunable, multi-material AM lattice absorbers—demonstrated here as shock-attenuating crutch-tip inserts for reducing upper-extremity overuse injury."

---

## 6. CONCRETE REWRITES

The following table provides specific, drop-in edit suggestions designed to stay within the 150-word TMS abstract limit while improving scope fit, tempering overstatements, and strengthening translational framing.

| Edit # | Current Text (quoted) | Suggested Replacement (≤25 words) | Rationale |
|---|---|---|---|
| 1 | “Bayesian-Optimized Multi-Material 3D-Printed Tensegrity Crutch Tips for Impact Attenuation” | “Closed-Loop Bayesian Optimization of Multi-Material 3D-Printed Tensegrity Lattices for Shock-Absorbing Assistive-Device Inserts” | Leads with AI/ML-in-manufacturing and broadens device framing to fit symposium scope (gongora2024acceleratingthedesign pages 6-7, gongora2024acceleratingthedesign pages 10-11, gongora2024acceleratingthedesign pages 2-4). |
| 2 | “commercial crutch tips still predominantly rely on rubber ferrules or bulky spring dampers” | “commercial crutch tips predominantly use passive rubber ferrules; existing spring-loaded dampers add bulk without architected tunability” | Acknowledges spring-loaded prior art while preserving the novelty of architected lattices (US11712394B1 pages 1-4, US11712394B1 pages 12-14, WO2010069070A1 pages 23-25). |
| 3 | “A prior-art survey found no crutch tip applying tensegrity architectures” | “A prior-art survey identified no tensegrity-based crutch-tip absorber, though tensegrity impact structures exist elsewhere” | More defensible because tensegrity impact absorbers are established outside crutch tips (pajunen2019designandimpact pages 5-7, pajunen2019designandimpact pages 1-2, pajunen2019designandimpact pages 8-9). |
| 4 | “an anticipated FDA Class I (21 CFR 890.3790) pathway under ISO 11334-1 applies” | “An anticipated Class I accessory pathway (21 CFR 890.3790) and ISO 11334-1 testing framework guide design verification” | Softens regulatory certainty and frames standards as verification guidance rather than settled classification (bandyopadhyay20213dprintingof pages 8-8, mottaghi2025opensource3dprintable pages 1-6). |
| 5 | “We present a shock-absorbing crutch-tip insert built from multi-material fused-filament-fabrication tensegrity-inspired lattices” | “We present an AI-driven design framework producing shock-absorbing crutch-tip inserts via multi-material FFF tensegrity-inspired lattices” | Foregrounds the AI/ML methodology to better match the symposium call (gongora2024acceleratingthedesign pages 6-7, zhang2021bayesianoptimisationfor pages 8-11, gongora2024acceleratingthedesign pages 2-4). |
| Bonus | — | “Crutch abandonment rates exceed 30%, and desktop FFF enables distributed, patient-tunable manufacturing with low material cost.” | Adds a market/translation hook using abandonment data and distributed-manufacturing economics (sugawara2018abandonmentofassistive pages 6-6, sugawara2018abandonmentofassistive pages 4-5, mottaghi2025opensource3dprintable pages 1-6). |


*Table: This table gives six drop-in abstract edits that improve scope fit, temper overstatements, and strengthen the lab-to-market framing. Each suggestion is grounded in the evidence gathered on Bayesian optimization, tensegrity impact structures, prior art, regulation, and assistive-device adoption.*

---

## 7. VERDICT

**Submit-with-substantial-revisions.** The abstract contains a genuinely novel application of tensegrity-based multi-material AM lattice design combined with Bayesian optimization, but its current framing under-leverages the AI/ML angle that is its strongest scope-fit hook, overstates the prior-art vacuum and regulatory certainty, and provides no quantitative results or translational metrics. With the revisions outlined above—foregrounding the BO/AI-driven design methodology, tempering prior-art and regulatory claims, and adding one concrete market/translation metric—the abstract can land as an acceptable contribution to this symposium's AI/ML-in-biomedical-manufacturing track. Without these revisions, it reads as an assistive-technology mechanical-design abstract that happens to mention Bayesian optimization, which is a scope mismatch for a symposium centered on implant biomaterials, biocompatibility, and in vitro/in vivo correlation.

References

1. (pajunen2019designandimpact pages 5-7): Kirsti Pajunen, Paul Johanns, Raj Kumar Pal, Julian J. Rimoli, and Chiara Daraio. Design and impact response of 3d-printable tensegrity-inspired structures. Materials & Design, 182:107966, Nov 2019. URL: https://doi.org/10.1016/j.matdes.2019.107966, doi:10.1016/j.matdes.2019.107966. This article has 100 citations and is from a highest quality peer-reviewed journal.

2. (gongora2024acceleratingthedesign pages 6-7): Aldair E. Gongora, Caleb Friedman, Deirdre K. Newton, Timothy D. Yee, Zachary Doorenbos, Brian Giera, Eric B. Duoss, Thomas Y.-J. Han, Kyle Sullivan, and Jennifer N. Rodriguez. Accelerating the design of lattice structures using machine learning. Scientific Reports, Jun 2024. URL: https://doi.org/10.1038/s41598-024-63204-7, doi:10.1038/s41598-024-63204-7. This article has 46 citations and is from a peer-reviewed journal.

3. (zhang2021bayesianoptimisationfor pages 8-11): Mimi Zhang, Andrew Parnell, Dermot Brabazon, and Alessio Benavoli. Bayesian optimisation for sequential experimental design with applications in additive manufacturing. Preprint, Jan 2021. URL: https://doi.org/10.48550/arxiv.2107.12809, doi:10.48550/arxiv.2107.12809. This article has 27 citations.

4. (pajunen2019designandimpact pages 7-8): Kirsti Pajunen, Paul Johanns, Raj Kumar Pal, Julian J. Rimoli, and Chiara Daraio. Design and impact response of 3d-printable tensegrity-inspired structures. Materials & Design, 182:107966, Nov 2019. URL: https://doi.org/10.1016/j.matdes.2019.107966, doi:10.1016/j.matdes.2019.107966. This article has 100 citations and is from a highest quality peer-reviewed journal.

5. (bandyopadhyay2018additivemanufacturingof pages 3-6): Amit Bandyopadhyay and Bryan Heer. Additive manufacturing of multi-material structures. Materials Science and Engineering: R: Reports, 129:1-16, Jul 2025. URL: https://doi.org/10.1016/j.mser.2018.04.001, doi:10.1016/j.mser.2018.04.001. This article has 711 citations.

6. (gongora2024acceleratingthedesign pages 2-4): Aldair E. Gongora, Caleb Friedman, Deirdre K. Newton, Timothy D. Yee, Zachary Doorenbos, Brian Giera, Eric B. Duoss, Thomas Y.-J. Han, Kyle Sullivan, and Jennifer N. Rodriguez. Accelerating the design of lattice structures using machine learning. Scientific Reports, Jun 2024. URL: https://doi.org/10.1038/s41598-024-63204-7, doi:10.1038/s41598-024-63204-7. This article has 46 citations and is from a peer-reviewed journal.

7. (bandyopadhyay20213dprintingof pages 8-8): Amit Bandyopadhyay, Sourabh Ghosh, Aldo R. Boccaccini, and Susmita Bose. 3d printing of biomedical materials and devices. Journal of Materials Research, 36:3713-3724, Oct 2021. URL: https://doi.org/10.1557/s43578-021-00407-y, doi:10.1557/s43578-021-00407-y. This article has 51 citations and is from a peer-reviewed journal.

8. (bandyopadhyay20203dprintingfor pages 1-2): Amit Bandyopadhyay, Indranath Mitra, and Susmita Bose. 3d printing for bone regeneration. Current Osteoporosis Reports, 18:505-514, Aug 2020. URL: https://doi.org/10.1007/s11914-020-00606-2, doi:10.1007/s11914-020-00606-2. This article has 120 citations and is from a peer-reviewed journal.

9. (US11712394B1 pages 1-4): Anthony L. Spatorico. Shock absorbing ferrule for assisted ambulation. Patent (US), 2023.

10. (US11712394B1 pages 12-14): Anthony L. Spatorico. Shock absorbing ferrule for assisted ambulation. Patent (US), 2023.

11. (mottaghi2025opensource3dprintable pages 1-6): Maryam Mottaghi, Morgan C. Woods, Laura Danier, Anita So, Jacob M. Reeves, and Joshua M. Pearce. Open-source 3d printable forearm crutch. PLOS ONE, Nov 2025. URL: https://doi.org/10.1371/journal.pone.0318987, doi:10.1371/journal.pone.0318987. This article has 5 citations and is from a peer-reviewed journal.

12. (gongora2024acceleratingthedesign pages 10-11): Aldair E. Gongora, Caleb Friedman, Deirdre K. Newton, Timothy D. Yee, Zachary Doorenbos, Brian Giera, Eric B. Duoss, Thomas Y.-J. Han, Kyle Sullivan, and Jennifer N. Rodriguez. Accelerating the design of lattice structures using machine learning. Scientific Reports, Jun 2024. URL: https://doi.org/10.1038/s41598-024-63204-7, doi:10.1038/s41598-024-63204-7. This article has 46 citations and is from a peer-reviewed journal.

13. (sugawara2018abandonmentofassistive pages 6-6): André T. Sugawara, Vinícius D. Ramos, Fábio M. Alfieri, and Linamara R. Battistella. Abandonment of assistive products: assessing abandonment levels and factors that impact on it. Disability and Rehabilitation: Assistive Technology, 13:716-723, Jan 2018. URL: https://doi.org/10.1080/17483107.2018.1425748, doi:10.1080/17483107.2018.1425748. This article has 230 citations and is from a peer-reviewed journal.

14. (chamorromoriana2016acompactforearm pages 8-10): Gema Chamorro-Moriana, José Sevillano, and Carmen Ridao-Fernández. A compact forearm crutch based on force sensors for aided gait: reliability and validity. Sensors, 16:925, Jun 2016. URL: https://doi.org/10.3390/s16060925, doi:10.3390/s16060925. This article has 36 citations and is from a peer-reviewed journal.

15. (bandyopadhyay20213dprintingof pages 2-3): Amit Bandyopadhyay, Sourabh Ghosh, Aldo R. Boccaccini, and Susmita Bose. 3d printing of biomedical materials and devices. Journal of Materials Research, 36:3713-3724, Oct 2021. URL: https://doi.org/10.1557/s43578-021-00407-y, doi:10.1557/s43578-021-00407-y. This article has 51 citations and is from a peer-reviewed journal.

16. (sugawara2018abandonmentofassistive pages 4-5): André T. Sugawara, Vinícius D. Ramos, Fábio M. Alfieri, and Linamara R. Battistella. Abandonment of assistive products: assessing abandonment levels and factors that impact on it. Disability and Rehabilitation: Assistive Technology, 13:716-723, Jan 2018. URL: https://doi.org/10.1080/17483107.2018.1425748, doi:10.1080/17483107.2018.1425748. This article has 230 citations and is from a peer-reviewed journal.

17. (brown2020commonproblemswith pages 1-7): Suzana Brown, Achilles Vairis, Ali M. Masoumifar, and Markos Petousis. Common problems with the conventional design of crutches: proposing a safer design and discussing the potential impact. Technology in Society, 60:101215, Feb 2020. URL: https://doi.org/10.1016/j.techsoc.2019.101215, doi:10.1016/j.techsoc.2019.101215. This article has 17 citations and is from a peer-reviewed journal.

18. (hugle2017prospectiveclinicalevaluation pages 1-3): Thomas Hügle, Ansgar Arnieri, Margerita Bünter, Stefan Schären, and Annegret Mündermann. Prospective clinical evaluation of a novel anatomic cuff for forearm crutches in patients with osteoarthritis. BMC Musculoskeletal Disorders, Mar 2017. URL: https://doi.org/10.1186/s12891-017-1459-7, doi:10.1186/s12891-017-1459-7. This article has 3 citations and is from a peer-reviewed journal.

19. (US11712394B1 pages 14-16): Anthony L. Spatorico. Shock absorbing ferrule for assisted ambulation. Patent (US), 2023.

20. (WO2010069070A1 pages 23-25): Sarah Doherty. Assistive mobility device. Patent (WO,US,CA), 2010.

21. (pajunen2019designandimpact pages 1-2): Kirsti Pajunen, Paul Johanns, Raj Kumar Pal, Julian J. Rimoli, and Chiara Daraio. Design and impact response of 3d-printable tensegrity-inspired structures. Materials & Design, 182:107966, Nov 2019. URL: https://doi.org/10.1016/j.matdes.2019.107966, doi:10.1016/j.matdes.2019.107966. This article has 100 citations and is from a highest quality peer-reviewed journal.

22. (pajunen2019designandimpact pages 8-9): Kirsti Pajunen, Paul Johanns, Raj Kumar Pal, Julian J. Rimoli, and Chiara Daraio. Design and impact response of 3d-printable tensegrity-inspired structures. Materials & Design, 182:107966, Nov 2019. URL: https://doi.org/10.1016/j.matdes.2019.107966, doi:10.1016/j.matdes.2019.107966. This article has 100 citations and is from a highest quality peer-reviewed journal.

23. (vangelatos2021strengththroughdefects pages 1-2): Zacharias Vangelatos, Haris Moazam Sheikh, Philip S. Marcus, Costas P. Grigoropoulos, Victor Z. Lopez, George Flamourakis, and Maria Farsari. Strength through defects: a novel bayesian approach for the optimization of architected materials. Science Advances, Oct 2021. URL: https://doi.org/10.1126/sciadv.abk2218, doi:10.1126/sciadv.abk2218. This article has 126 citations and is from a highest quality peer-reviewed journal.